Quan, Chuntao
Wu, Zhijie
Xiong, Juan
Li, Manqing
Fu, Yu
Su, Jiaying
Wang, Yue
Ning, Lvwen
Zhang, Deju
Xie, Ni
Funding for this research was provided by:
National Natural Science Foundation of China, China ((No. 82172356), (No. 81972003), (No. 82203519))
the Natural Science Foundation of Guangdong, China ((No. 2021A1515012144))
Natural Science Foundation of Shenzhen, China (JCYJ20230807115112024)
Article History
Received: 27 April 2023
Accepted: 22 November 2023
First Online: 30 November 2023
Declarations
:
: All in vivo experiments were approved by the Institutional Animal Care and Use Committee of Shenzhen University (SZU-IACUC-2022–00136) and followed the Guide for the Care and Use of Laboratory Animals. All human breast cancer sample acquisitions were approved by the Committee on Ethics of Shenzhen Second People’s Hospital, Shenzhen University. Written informed consent was obtained from all the participants.
: The authors have declared that no competing interest exists.